Quent Capital’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Sell
2,274
-1,148
-34% -$267K 0.03% 218
2025
Q4
$918K Buy
3,422
+550
+19% +$140K 0.07% 144
2025
Q3
$708K Sell
2,872
-14
-0.5% -$3.65K 0.06% 124
2025
Q2
$863K Sell
2,886
-57
-2% -$17.4K 0.08% 104
2025
Q1
$918K Buy
2,943
+43
+1% +$15.2K 0.1% 93
2024
Q4
$1.02M Buy
2,900
+101
+4% +$36.4K 0.11% 90
2024
Q3
$988K Sell
2,799
-171
-6% -$56.2K 0.1% 114
2024
Q2
$901K Sell
2,970
-347
-10% -$106K 0.1% 111
2024
Q1
$1.15M Buy
3,317
+56
+2% +$20.4K 0.13% 92
2023
Q4
$1.14M Buy
3,261
+271
+9% +$87.4K 0.15% 80
2023
Q3
$918K Buy
2,990
+80
+3% +$25.2K 0.14% 89
2023
Q2
$898K Buy
2,910
+110
+4% +$32K 0.14% 89
2023
Q1
$800K Buy
2,800
+2
+0.1% +$545 0.14% 96
2022
Q4
$747K Buy
2,798
+61
+2% +$16.9K 0.14% 98
2022
Q3
$704K Buy
2,737
+313
+13% +$90.5K 0.15% 91
2022
Q2
$673K Buy
2,424
+3
+0.1% +$901 0.14% 89
2022
Q1
$817K Sell
2,421
-2,291
-49% -$773K 0.15% 90
2021
Q4
$1.95M Buy
+4,712
New +$1.72M 0.41% 48

Other funds holding ACN

Quent Capital's ACN Position: Q1 2026 in Review

Quent Capital reduced its Accenture (ACN) stake by 34% in Q1 2026, selling an estimated $267K and leaving 2,274 shares worth $451K. The position accounts for 0.03% of the portfolio, ranked #218.

Quent Capital first reported a position in ACN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.95M in Q4 2021. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Quent Capital held 2,274 shares of Accenture worth $451K as of Q1 2026.
  • Quent Capital sold 1,148 Accenture shares in Q1 2026, an estimated $267K.
  • Accenture made up 0.03% of Quent Capital's portfolio in Q1 2026, its #218 holding.
  • Quent Capital first reported a position in Accenture in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Accenture position peaked at $1.95M in Q4 2021.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.